| Value | ₹0.25 Cr |
|---|
BSE filing, NSE: PDSL. Summary written from the filing by ALFA Finder's alert engine.
PDS Ltd: key numbers
- Share price
- ₹335.65
- Market cap
- ₹4,749 Cr
- Revenue (annual)
- ₹13,110 Cr
- Net profit (annual)
- ₹111.7 Cr
- P/E (TTM)
- 40.4×Sector 49.0×
- Promoter holding
- 61.36%-0.01% QoQ
- FII holding
- 4.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from PDS Ltd
All →PDS Board Meeting Date
PDS Ltd intimated a board meeting on November 4, 2026 to consider Q2/H1 unaudited financial results and possible interim dividend. Trading window closure is also noted.
PDS Acquisition Worth ₹0.05 Cr
PDS Limited's step-down subsidiary, PDS Sourcing, acquired the remaining 49% stake in DBS Lifestyle Limited, Hong Kong for ₹0.05 Crore to consolidate ownership.
- Value
- ₹0.05 Cr
PDS Employee Stock Options
PDS Limited allotted 18,750 equity shares under its Employee Stock Option Plan 2021. This increases the company's issued and paid-up share capital.
PDS Merger & Restructuring
PDS Limited divested its entire stake in Northern Brands Limited, UK, held by step-down subsidiary Northern Apparel Limited, HK, for a consideration of £1.
PDS Other Announcement
PDS Ltd submitted its quarterly shareholding pattern disclosure as per SEBI regulations, outlining the distribution of shares among promoter and public shareholders.
PDS Employee Stock Options
PDS Ltd disclosed that its ESOP Trust acquired 14,000 equity shares worth approximately ₹0.50 Crore via market purchase. The transaction increases the trust's holding.
- Value
- ₹0.50 Cr
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date